Tech Company Financing Transactions
Precision Compounding Pharmacy Funding Round
Precision Compounding Pharmacy closed a Seed venture capital round on 11/3/2023. Investors included Right Side Capital Management.
Transaction Overview
Company Name
Announced On
11/3/2023
Transaction Type
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to enhance its suite of services, broaden its reach, and drive innovation in the pharmacy industry.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2657 Merrick Rd
Bellmore, NY 11710
USA
Bellmore, NY 11710
USA
Phone
Email Address
Overview
In today's day and age, the one size fits all approach to pharmaceutical therapy is falling out of favor. Patients need to be recognized as individuals with different genetic makeups. Prescription regimens need to be viewed as unique protocols as specific as a fingerprint. With capabilities of customizing individual formulations, Precision Compounding Pharmacy makes it easy to individualize patient care. We pride ourselves on our high levels of communication, affordable compounded formulations, clinical consultations, and quick door to door deliveries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christian Stella
Browse more venture capital transactions:
Prev: 11/3/2023: Ambercycle venture capital transaction
Next: 11/3/2023: Infinitum venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs